PHYO.F Stock Overview
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
IXICO plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.15 |
| 52 Week High | UK£0.30 |
| 52 Week Low | UK£0.003 |
| Beta | 0.67 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -88.37% |
| 5 Year Change | -54.41% |
| Change since IPO | -81.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHYO.F | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 0% | -5.9% | -3.7% |
| 1Y | n/a | -5.5% | 20.2% |
Return vs Industry: Insufficient data to determine how PHYO.F performed against the US Life Sciences industry.
Return vs Market: Insufficient data to determine how PHYO.F performed against the US Market.
Price Volatility
| PHYO.F volatility | |
|---|---|
| PHYO.F Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 7.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PHYO.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PHYO.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 89 | Giulio Cerroni | ixico.com |
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer.
IXICO plc Fundamentals Summary
| PHYO.F fundamental statistics | |
|---|---|
| Market cap | US$5.26m |
| Earnings (TTM) | -US$1.51m |
| Revenue (TTM) | US$8.53m |
0.6x
P/S Ratio-3.5x
P/E RatioIs PHYO.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHYO.F income statement (TTM) | |
|---|---|
| Revenue | UK£6.67m |
| Cost of Revenue | UK£3.40m |
| Gross Profit | UK£3.27m |
| Other Expenses | UK£4.45m |
| Earnings | -UK£1.18m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.024 |
| Gross Margin | 49.06% |
| Net Profit Margin | -17.67% |
| Debt/Equity Ratio | 0% |
How did PHYO.F perform over the long term?
See historical performance and comparison